Drug induced hypoprolactinemia

Area of Science:

• Endocrinology
• Pharmacology
• Neuroscience

Background:

• Prolactin secretion is regulated by dopamine receptors.
• Hyperprolactinemia is well-characterized, but hypoprolactinemia's effects are less understood.
• Medications can influence prolactin levels, leading to hypoprolactinemia.

Purpose of the Study:

• To review the clinical implications of drug-induced hypoprolactinemia.
• To highlight potential adverse effects beyond lactation impairment.
• To increase awareness among clinicians regarding this condition.

Main Methods:

• Literature review of studies on drug-induced hypoprolactinemia.
• Analysis of clinical data from patients treated with specific medications.
• Discussion of the role of dopamine receptor interactions.

Main Results:

• Hypoprolactinemia is associated with potential negative changes in glucose metabolism, sexual function, and psychological health.
• Drug-induced hypoprolactinemia is often reversible upon medication dose adjustment.
• Common causes include dopamine agonists like cabergoline and bromocriptine, and antipsychotics like aripiprazole.

Conclusions:

• Drug-induced hypoprolactinemia requires clinical consideration due to its potential detrimental effects.
• Patients on certain medications need careful evaluation for associated comorbidities.
• Further research is needed to fully elucidate the consequences of hypoprolactinemia.